Package 51316-740-04

{"route": ["ORAL"], "spl_id": "8500c678-d766-4646-8939-7c38ba5b7f76", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0000000000000"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1020138"], "spl_set_id": ["3148f80f-8a0d-4b6c-85be-79085fc04444"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["CVS PHARMACY"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (51316-740-04)  / 118 mL in 1 BOTTLE", "package_ndc": "51316-740-04", "marketing_start_date": "20230217"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (51316-740-08)  / 237 mL in 1 BOTTLE", "package_ndc": "51316-740-08", "marketing_start_date": "20230217"}], "brand_name": "CVS Maximum Strength", "product_id": "51316-740_8500c678-d766-4646-8939-7c38ba5b7f76", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "51316-740", "generic_name": "Dextromethorphan HBr, Guaifenesin", "labeler_name": "CVS PHARMACY", "product_type": "HUMAN OTC DRUG", "brand_name_base": "CVS", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/20mL"}, {"name": "GUAIFENESIN", "strength": "400 mg/20mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230217", "listing_expiration_date": "20261231"}